MarketScreener Editorial Features Hansa Biopharma AB Nasdaq Stockholm
Equities
SE0002148817
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.61 SEK | -82.48% | -5.78% | -38.73% |
Apr. 18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
Apr. 18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- HNSA Stock
- Stock
- News Hansa Biopharma AB
- MarketScreener Editorial Features